Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding protein with multiple splicing (RBPMS) is a member of the RNA recognition motif (RRM) family of RNA-binding proteins, characterized by a single RRM at the N-terminus[1][4]. RBPMS is primarily known as a post-transcriptional regulator that mediates alternative splicing by binding to specific RNA sequence motifs (tandem CAC trinucleotide repeats) near regulated exons, acting as both a splicing activator and repressor depending on its target[1][2][3][6]. It plays a key role in the development and function of cardiac and smooth muscle cells, regulating the inclusion of exons in structural and contractile genes critical for heart and vascular function[3][6]. RBPMS interacts with core spliceosome components, other splicing factors, and transcription regulators, and may also influence mRNA translation and localization[3][5]. Dysregulation of RBPMS has been linked to congenital heart defects, dilated cardiomyopathy, and possibly to some cancers[1][3][6]. RBPMS is highly specific as a marker for retinal ganglion cells in the retina, making it a valuable tool in neuroscience research[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding protein with multiple splicing (RBPMS).